RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
-4.26%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.49B
AUM Growth
+$1.49B
(-6.3%)
Cap. Flow
+$12.7M
Cap. Flow
% of AUM
0.85%
Top 10 Holdings %
Top 10 Hldgs %
30.22%
Holding
143
New
5
Increased
55
Reduced
19
Closed
10
Top Buys
| 1 |
UnitedHealth
UNH
|
$26.4M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$24.2M |
| 3 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$12.5M |
| 4 |
Bristol-Myers Squibb
BMY
|
$11.7M |
| 5 |
Merck
MRK
|
$9.57M |
Top Sells
| 1 |
Pfizer
PFE
|
$35.8M |
| 2 |
HCA Healthcare
HCA
|
$32.5M |
| 3 |
McKesson
MCK
|
$13.7M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$9.24M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$6.83M |
Sector Composition
| 1 | Healthcare | 81.35% |
| 2 | Financials | 4.56% |
| 3 | Industrials | 0.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSRO
1
DELISTED
TESARO, Inc.
TSRO
| $82.5M | 5.52% | 613,500 -13,000 | -2% | -$1.75M |
|
|
ALXN
2
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $56.9M | 3.81% | 465,000 +197,750 | +74% | +$24.2M |
|
|
AET
3
DELISTED
Aetna Inc
AET
| $54.7M | 3.66% | 441,000 +900 | +0.2% | +$112K |
|
|
4
Merck
MRK
$210B
| $44.2M | 2.95% | 750,000 +162,500 | +28% | +$9.57M |
|
|
GWPH
5
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $39.8M | 2.66% | 356,000 +31,000 | +10% | +$3.46M |
|
6
Acadia Healthcare
ACHC
$2.12B
| $38.3M | 2.56% | 1,157,500 +232,822 | +25% | +$7.71M |
|
|
AGN
7
DELISTED
Allergan plc
AGN
| $34.9M | 2.33% | 166,000 -20,000 | -11% | -$4.2M |
|
|
RDUS
8
DELISTED
Radius Health, Inc.
RDUS
| $34.6M | 2.32% | 910,250 +18,250 | +2% | +$694K |
|
9
Cigna
CI
$80.3B
| $33.6M | 2.25% | 252,000 +23,500 | +10% | +$3.13M |
|
|
WCG
10
DELISTED
Wellcare Health Plans, Inc.
WCG
| $32.1M | 2.15% | 234,500 | – | – |
|
|
ONCE
11
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $31.2M | 2.09% | 625,000 | – | – |
|
12
Intuitive Surgical
ISRG
$170B
| $30.4M | 2.04% | 48,000 +3,000 | +7% | +$1.9M |
|
13
Aclaris Therapeutics
ACRS
$209M
| $29.9M | 2% | 1,100,000 +84,000 | +8% | +$2.28M |
|
14
Ardelyx
ARDX
$1.53B
| $28.4M | 1.9% | 2,000,000 +25,000 | +1% | +$355K |
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $28.1M | 1.88% | 242,500 -12,000 | -5% | -$1.39M |
|
|
16
UnitedHealth
UNH
$281B
| $26.4M | 1.77% | +165,000 | New | +$26.4M |
|
|
17
Bristol-Myers Squibb
BMY
$96B
| $26.3M | 1.76% | 450,000 +200,000 | +80% | +$11.7M |
|
18
Collegium Pharmaceutical
COLL
$1.22B
| $24.9M | 1.67% | 1,600,000 +55,000 | +4% | +$856K |
|
|
AAAP
19
DELISTED
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
| $24.9M | 1.67% | 930,000 | – | – |
|
20
Eli Lilly
LLY
$657B
| $23.9M | 1.6% | 325,000 +49,000 | +18% | +$3.6M |
|
|
MDCO
21
DELISTED
Medicines Co
MDCO
| $23.7M | 1.59% | 699,500 +18,500 | +3% | +$628K |
|
|
SHPG
22
DELISTED
Shire pic
SHPG
| $23.4M | 1.56% | 137,200 +4,700 | +4% | +$801K |
|
23
Pacira BioSciences
PCRX
$1.2B
| $23M | 1.54% | 713,000 +209,000 | +41% | +$6.75M |
|
24
Gilead Sciences
GILD
$140B
| $19.8M | 1.32% | 276,500 -67,500 | -20% | -$4.83M |
|
25
Theravance Biopharma
TBPH
$699M
| $19.1M | 1.28% | 600,000 | – | – |
|